C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis.
Mulligan JK, Patel K, Williamson T, Reaves N, Carroll W, Stephenson SE, Gao P, Drake RR, Neely BA, Tomlinson S, Schlosser RJ, Atkinson C.
Mulligan JK, et al. Among authors: reaves n.
Mucosal Immunol. 2018 Sep;11(5):1375-1385. doi: 10.1038/s41385-018-0048-x. Epub 2018 Jun 15.
Mucosal Immunol. 2018.
PMID: 29907871
Free PMC article.